| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |